Genomics is changing how diseases are diagnosed, how treatments are chosen and how health systems approach prevention, driven by a much better understanding of individual genetic profiles.
But genomics was never just a sequencing technology problem. The harder task is managing the information it generates. Genomic information behaves differently to most other health information: it stays relevant for a person's whole life, can affect care decisions decades after it was first generated, has implications for family members as well as the patient, and needs to support clinical care, research and future discovery all at once.
This was the challenge that inspired the National Approach to Genomic Information Management, or NAGIM. As principal consultant on the project, I worked with Queensland Genomics, governments, clinicians, researchers and other stakeholders to develop a national blueprint for the management of genomic information in Australia.
Genomic information must be managed as part of the broader digital health ecosystem.
Why the blueprint was needed
Australia was investing heavily in genomics. Clinical programs were expanding, research initiatives were producing increasingly large and valuable datasets, and governments were investing in precision medicine capabilities. What was less clear was how genomic information would be managed over the long term.
The NAGIM Blueprint was developed as an AHMAC-funded project to establish a future state for national genomic information management and to help harmonise investments across clinical systems and research infrastructure. Rather than proposing a single system, it examined the broader ecosystem required to support genomic medicine: information management principles, data governance, standards and interoperability, architecture, lifecycle management, consent, Indigenous data considerations and national coordination.
A blueprint built on principles
Technology changes. Standards evolve. New clinical and research use cases emerge. Governance arrangements change. Principles provide continuity through those changes. The blueprint established a framework of principles spanning genomic medicine, genomics research, translational genomics, data management, consumer engagement and Indigenous genomics, intended as guardrails for future policy and implementation decisions.
From genomic data to digital health infrastructure
A recurring theme was that genomic information should not be viewed as a specialist data problem. It is a digital health problem. Data quality, information governance, privacy, consent, identity, terminology, standards and long-term stewardship: the same issues that affect broader digital health reform, only amplified in genomics.
The blueprint highlighted the need for nationally coordinated approaches to data governance and standards, together with architectural foundations capable of supporting information sharing across organisational and jurisdictional boundaries.
A foundation for the future
The NAGIM Blueprint was never intended to be the end of the journey. It was designed to provide a foundation from which implementation activities could proceed. Subsequent work across Australia has continued to build on many of the concepts first articulated through the project, including governance arrangements, standards adoption, information sharing approaches and architectural considerations for genomics.
Conclusion
Genomic medicine tends to get discussed purely as a story of scientific discovery. The science matters, but its long-term success depends just as much on how the information gets managed. The NAGIM Blueprint tried to address that by giving Australia a national framework for treating genomic information as a strategic health asset, not a pile of disconnected datasets.
As Australia's digital health transformation continues, connecting information across clinical care, research and policy will only matter more. That's the lesson I took from the project, and it still shapes how I work today.
Read more about progress on the Blueprint's implementation at Australian Genomics.